
    
      Study population: Age 18 - 75, male or non-pregnant female; stable or unstable angina with
      evidence of myocardial ischemia, or patient with myocardial infarction; coronary angiography
      reveals stenosis lesions; discovery of ADP induced platelet inhibition rate < 50% and MAADP >
      47mm via thromboelastography (indicating low responsiveness to Clopidogrel with high risk for
      stent thrombosis formation); is able to understand the objective of the trial, takes part
      voluntarily and signs the written informed consent form.
    
  